Ladenburg lowered the firm’s price target on Strata Skin Sciences to $3.20 from $3.80 and keeps a Buy rating on the shares post the Q3 report. Going forward, equipment revenue is expected to be more muted but largely offset by the increase of recurring revenue based on system utilization, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SSKN:
- STRATA Skin Sciences Reports Third Quarter 2023 Revenue
- STRATA Skin Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023
- STRATA Skin Sciences, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Strata Skin Sciences announces CEO Moccia has stepped down, Rafaeli new CEO
